Egaten
Active Ingredient(s): TriclabendazoleFDA Approved: * February 13, 2019
Pharm Company: * NOVARTIS PHARMS CORP
Category: Antiprotozoal / Anthelmintic
Triclabendazole, sold under the brand name Egaten among others, is a medication used to treat fascioliasis and paragonimiasis.[1] It is very effective for both conditions.[1] Treatment in hospital may be required.[1] It is taken by mouth with typically one or two doses being required.[1] Side effects are generally few, but can include abdominal pain and headaches.[1] Biliary colic may occur due to dying worms.&... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.